Efficacy, Safety, and Tolerability of Efgartigimod in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Results from the ADHERE Trial (PL5.002)Jeffrey Allen,Ivana Basta,Christian Eggers,Jeffrey Guptill,Kelly Gwathmey, Channa Hewamadduma,Erik Hofman,Yessar Hussain,Satoshi Kuwabara,Frank Leypoldt,Jie Lin,Marta Lipowska, Murray Lowe, Giuseppe Lauria Pinter,Luis Querol,Niraja Suresh,Anissa Tse,Peter Ulrichts,Pieter Van Doorn,Benjamin Van Hoorick,Ryo Yamasaki,Richard LewisNeurology（2024）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
